Copyright Reports & Markets. All rights reserved.

Post-pandemic Era-Global Long-acting Injectable Medications Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Request for Sample of this report
Buy now

Table of Contents

    Global Long-acting Injectable Medications Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

      1 Market Scope

      • 1.1 Product Details and Introduction
        • 1.1.1 First-generation -Product Introduction and Major Manufacturers
        • 1.1.2 Second-generation -Product Introduction and Major Manufacturers
      • 1.2 Market Snapshot
        • 1.2.1 Major Companies Overview
        • 1.2.2 Market Concentration
        • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

      2 Regional Market Analysis

      • 2.1 China Long-acting Injectable Medications Status and Prospect (2015-2026)
        • 2.1.1 China Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
        • 2.1.2 China Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.2 EU Long-acting Injectable Medications Status and Prospect (2015-2026)
        • 2.2.1 EU Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
        • 2.2.2 EU Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.3 USA Long-acting Injectable Medications Status and Prospect (2015-2026)
        • 2.3.1 USA Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
        • 2.3.2 USA Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.4 Japan Long-acting Injectable Medications Status and Prospect (2015-2026)
        • 2.4.1 Japan Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
        • 2.4.2 Japan Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.5 India Long-acting Injectable Medications Status and Prospect (2015-2026)
        • 2.5.1 India Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
        • 2.5.2 India Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.6 Southeast Asia Long-acting Injectable Medications Status and Prospect (2015-2026)
        • 2.6.1 Southeast Asia Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
        • 2.6.2 Southeast Asia Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.7 South America Long-acting Injectable Medications Status and Prospect (2015-2026)
        • 2.7.1 South America Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
        • 2.7.2 South America Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.8 Long-acting Injectable Medications Status and Prospect (2015-2026)
        • 2.8.1 Long-acting Injectable Medications Market Size and Growth Rate (2015-2026)
        • 2.8.2 Long-acting Injectable Medications Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

      3 Global Long-acting Injectable Medications Market Assessment by Segment

      • 3.1 Global Long-acting Injectable Medications Capacity and Growth Rate
      • 3.2 Global Long-acting Injectable Medications Sales by Type
      • 3.3 Global Long-acting Injectable Medications Sales Revenue by Type
      • 3.4 Global Long-acting Injectable Medications Consumption by Application

      4 Global Long-acting Injectable Medications Market Assessment by Regions

      • 4.1 Global Long-acting Injectable Medications Production Analysis and Forecast by Regions (2015-2026)
      • 4.2 Global Long-acting Injectable Medications Sales Analysis and Forecast by Regions (2015-2026)
      • 4.3 Global Long-acting Injectable Medications Sales Revenue Analysis and Forecast by Regions (2015-2026)

      5 Value Chain (Impact of COVID-19)

      • 5.1 Long-acting Injectable Medications Value Chain Analysis
        • 5.1.1 Upstream
        • 5.1.2 Downstream
      • 5.2 COVID-19 Impact on Long-acting Injectable Medications Industry
        • 5.2.1 Industrial Policy Issued Under the Epidemic Situation
      • 5.3 Cost-Under the Epidemic Situation
        • 5.3.1 Cost of Raw Material
      • 5.4 Channel Analysis
        • 5.4.1 Distribution Channel-Under the Epidemic Situation
        • 5.4.2 Distributors

      6 Competitive Landscape

      • 6.1 Global Long-acting Injectable Medications Capacity Market Share of Manufacturers (2019-2020)
      • 6.2 Global Long-acting Injectable Medications Sales Market Share of Manufacturers (2019-2020)
      • 6.3 Global Long-acting Injectable Medications Sales Revenue Market Share of Manufacturers (2019-2020)

      7 Long-acting Injectable Medications Competitive Analysis

      • 7.1 Eli Lilly
        • 7.1.1 Eli Lilly Company Profiles
        • 7.1.2 Eli Lilly Product Introduction
        • 7.1.3 Eli Lilly Long-acting Injectable Medications Production, Revenue (2015-2020)
        • 7.1.4 SWOT Analysis
      • 7.2 Nanomi
        • 7.2.1 Nanomi Company Profiles
        • 7.2.2 Nanomi Product Introduction
        • 7.2.3 Nanomi Long-acting Injectable Medications Production, Revenue (2015-2020)
        • 7.2.4 SWOT Analysis
      • 7.3 Alkermes
        • 7.3.1 Alkermes Company Profiles
        • 7.3.2 Alkermes Product Introduction
        • 7.3.3 Alkermes Long-acting Injectable Medications Production, Revenue (2015-2020)
        • 7.3.4 SWOT Analysis
      • 7.4 Zogenix
        • 7.4.1 Zogenix Company Profiles
        • 7.4.2 Zogenix Product Introduction
        • 7.4.3 Zogenix Long-acting Injectable Medications Production, Revenue (2015-2020)
        • 7.4.4 SWOT Analysis
      • 7.5 DURECT
        • 7.5.1 DURECT Company Profiles
        • 7.5.2 DURECT Product Introduction
        • 7.5.3 DURECT Long-acting Injectable Medications Production, Revenue (2015-2020)
        • 7.5.4 SWOT Analysis
      • 7.6 Johnson & Johnson
        • 7.6.1 Johnson & Johnson Company Profiles
        • 7.6.2 Johnson & Johnson Product Introduction
        • 7.6.3 Johnson & Johnson Long-acting Injectable Medications Production, Revenue (2015-2020)
        • 7.6.4 SWOT Analysis
      • 7.7 MedinCell
        • 7.7.1 MedinCell Company Profiles
        • 7.7.2 MedinCell Product Introduction
        • 7.7.3 MedinCell Long-acting Injectable Medications Production, Revenue (2015-2020)
        • 7.7.4 SWOT Analysis
      • 7.8 Mapi Pharma
        • 7.8.1 Mapi Pharma Company Profiles
        • 7.8.2 Mapi Pharma Product Introduction
        • 7.8.3 Mapi Pharma Long-acting Injectable Medications Production, Revenue (2015-2020)
        • 7.8.4 SWOT Analysis
      • 7.9 Oakwood Labs
        • 7.9.1 Oakwood Labs Company Profiles
        • 7.9.2 Oakwood Labs Product Introduction
        • 7.9.3 Oakwood Labs Long-acting Injectable Medications Production, Revenue (2015-2020)
        • 7.9.4 SWOT Analysis
      • 7.10 GSK
        • 7.10.1 GSK Company Profiles
        • 7.10.2 GSK Product Introduction
        • 7.10.3 GSK Long-acting Injectable Medications Production, Revenue (2015-2020)
        • 7.10.4 SWOT Analysis
      • 7.11 Pharmathen
      • 7.12 Kashiv BioSciences

      8 Conclusion

      Summary

      World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

      Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

      XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

      This research report indicated that the global Long-acting Injectable Medications market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

      Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Long-acting Injectable Medications Market by XYZResearch Include
      China
      EU
      North America
      Japan
      India
      Southeast Asia
      South America
      Middle East and Africa
      Competitive Analysis; Who are the Major Players in Long-acting Injectable Medications Market?
      Eli Lilly
      Nanomi
      Alkermes
      Zogenix
      DURECT
      Johnson & Johnson
      MedinCell
      Mapi Pharma
      Oakwood Labs
      GSK
      Pharmathen
      Kashiv BioSciences
      ...
      Major Type of Long-acting Injectable Medications Covered in XYZResearch report:
      First-generation
      Second-generation
      Application Segments Covered in XYZResearch Market
      Schizophrenia
      Contraception
      HIV
      Other

      For any other requirements, please feel free to contact us and we will provide you customized report.
      Buy now